Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced ...

Efforts to efficiently manufacture human neurons from induced pluripotent stem cells (iPSCs) are rapidly transforming the landscape of neuroscience research, drug discovery, and emerging cell-based ...

Independent analyses have shown that Amazon gives its house brands a privileged perch. The Markup found that Amazon’s brands and exclusives (despite being a small share of the catalogue) captured the ...

A strong Jamaican contingent featured in the opening ceremony for the International Practical Shooting Confederation (IPSC) Handgun World Championships in Klerksdorp, South Africa, on Sunday. The main ...

Researchers across discovery and translational biomedicine recognize the critical importance of iPSCs in core applications beyond regenerative medicine. Large, global biobanks offer researchers ...

In the study, "An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis," published in Cell, researchers engineered an allogeneic cell therapy, QN-139b, to deplete pathogenic B ...

AUSTIN, Texas--(BUSINESS WIRE)--Gameto, a clinical-stage biotech company developing iPSC-based therapies for women’s health, today announced that the U.S. Food and Drug Administration (FDA) has ...

SEATTLE--(BUSINESS WIRE)--Pluristyx, a leading provider of Good Manufacturing Practices (GMP), cutting-edge, induced pluripotent stem cell (iPSC) technologies, today announced the immediate ...

I was entering the miseries of seventh grade in the fall of 1980 when a friend dragged me into a dimly lit second-floor room. The school had recently installed a newfangled Commodore PET computer, a ...

Sixty years ago, on May 1, 1964, at 4 am in the morning, a quiet revolution in computing began at Dartmouth College. That’s when mathematicians John G. Kemeny and Thomas E. Kurtz successfully ran the ...